🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares the immune response to the proposed biosimilar PF-06881...
Status
Completed
Location
Seaview A Quotient Clinical Business
Start Date
2017-10-27
Trial ID
NCT03273842
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956
This phase II trial tests how well etoposide, prednisone, vincristine, cycl...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-05-08
Trial ID
NCT06738368
This will be an open-label, randomized, 2-treatment, 2-period, crossover si...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2022-02-10
Trial ID
NCT05194579
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of ruxoliti...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-12-16
Trial ID
NCT07278856
Treatments Being Tested
This phase II trial studies the best approach to combine chemotherapy and r...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2021-07-13
Trial ID
NCT04684368
This phase III trial compares immunotherapy drugs (nivolumab or brentuximab...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2019-08-29
Trial ID
NCT03907488
This phase III trial compares the effects of nivolumab with chemo-immunothe...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2021-10-05
Trial ID
NCT04759586
Treatments Being Tested
This phase II/III trial compares the effect of adding durvalumab to chemoth...
Status
Recruiting
Location
Kingman Regional Medical Center
Start Date
2021-11-12
Trial ID
NCT04628767
This phase II clinical trial studies how well dasatinib followed by stem ce...
Status
Completed
Location
Stanford Cancer Institute Palo Alto
Start Date
2010-12-14
Trial ID
NCT01256398
Treatments Being Tested